Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

NCT01124539 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
GBM
Gliosarcoma

Interventions

DRUG: AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin)

Sponsor

Arno Therapeutics